Xeris Biopharma Holdings XERS
NASDAQ XERS
$8.69 -0.09 (-1.08%)
At close: Aug 20, 2026 · 2:54 PM UTC

Xeris Biopharma Holdings (XERS) EPS (Basic) Growth (5y) (2025 - 2026)

Xeris Biopharma Holdings (XERS) EPS (Basic) Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn
3 Zoetis 31.53 Bn 29.85 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn
5 United Therapeutics 22.13 Bn 19.47 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Xeris Biopharma Holdings 1.50 Bn 1.38 Bn 79.59 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 15.37%
Mar 31, 2026 15.37%
Dec 31, 2025 16.38%
Sep 30, 2025 15.00%